4//SEC Filing
Diaz Allene M. 4
Accession 0000874015-24-000178
CIK 0000874015other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 5:02 PM ET
Size
11.5 KB
Accession
0000874015-24-000178
Insider Transaction Report
Form 4
Diaz Allene M.
Director
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-07-15−4,677→ 4,079 totalExercise: $0.00→ Common Stock (4,677 underlying) - Sale
Common Stock
2024-07-16$50.17/sh−737$36,975→ 15,716 total - Exercise/Conversion
Common Stock
2024-07-15+4,677→ 17,353 total - Sale
Common Stock
2024-07-16$48.94/sh−900$44,044→ 16,453 total
Footnotes (6)
- [F1]Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
- [F2]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 3, 2023
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.745 to $49.461 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.0825 to $50.245 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) on this Form 4.
- [F5]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- [F6]Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001773314
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 5:02 PM ET
- Size
- 11.5 KB